$CTIC News Insider filings one way to track tricky

New Post Public Reply Private Reply Replies (0) Message Board

Jan 10, 2014 at 5:08 PM

$CTIC News

Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com

Time to Analyze Small-Caps Again 1:00 p.m. Today - RealMoney.com
Cell Therapeutics Inc. (CTIC) Shares March Higher, Can It Continue? - Tale of the Tape 7:47 a.m. Jan. 7, 2014 - Zacks.com
BAX Recalls Parenteral Nutrition Injections - Analyst Blog 7:15 p.m. Jan. 6, 2014 - Zacks.com
Is Cell Therapeutics Turning Over A New Leaf In 2014? 11:35 a.m. Jan. 6, 2014 - Seeking Alpha
Cell Therapeutics rallies on NICE nod for Pixuvri 9:02 a.m. Jan. 6, 2014 - Seeking Alpha
FDA lifts partial clinical hold on Cell Therapeutics drug 7:04 a.m. Jan. 2, 2014 - Seeking Alpha
Cell Therapeutics Announces Removal of Partial Clinical Hold on Tosedostat 6:19 a.m. Jan. 2, 2014 - benzinga.com
2 Speculative, But Attractive $2 Biotech Plays 7:19 a.m. Dec. 30, 2013 - Seeking Alpha
BAX Up on FDA Nod and CE Marking - Analyst Blog 5:30 p.m. Dec. 24, 2013 - Zacks.com
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 4:56 a.m. Dec. 18, 2013 - benzinga.com
Cell Therapeutics outlines data from tosedostat study in AML or MDS 9:40 a.m. Dec. 10, 2013 - Seeking Alpha
US Stock Futures Up Ahead Of Wholesale Trade Data 5:59 a.m. Dec. 10, 2013 - benzinga.com
Cell Therapeutics Presents Interim Results from Phase 2 Tosedostat Trial in Older Patients with AML or MDS at ASH 5:07 a.m. Dec. 10, 2013 - benzinga.com
Cell Therapeutics outlines integrated Phase 2 pacritinib data at ASH 3:28 p.m. Dec. 9, 2013 - Seeking Alpha
Cell Therapeutics CEO Presents at Piper Jaffray Healthcare Conference (Transcript) 10:27 a.m. Dec. 4, 2013 - Seeking Alpha
Cell Therapeutics: Solid Pipeline, Partnerships And Upside 5:34 a.m. Nov. 28, 2013 - Seeking Alpha
Baxter, Cell Therapeutics to Jointly Develop Pacritinib - Analyst Blog 3:00 p.m. Nov. 19, 2013 - Zacks.com
One JAK Erases Another, But Space Is Not Dead Yet 3:04 p.m. Nov. 18, 2013 - Seeking Alpha
Heavy Early Morning Activity On Cell Therapeutics (CTIC) 9:14 a.m. Nov. 18, 2013 - TheStreet.com
BlackBerry Gets Downgraded, Vanda’s Meteoric Rise, and 3 More Hot Stocks 1:53 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet

Study Updates, Notices, Quarterly Reports, and Revenue Guidance Updates - Research Report on NPS Pharmaceuticals, Oramed, PAREXEL, PhotoMedex, and Cell Therapeutics 8:00 a.m. Jan. 7, 2014 - PR Newswire
PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from NICE 1:30 a.m. Jan. 6, 2014 - PR Newswire
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat 1:30 a.m. Jan. 2, 2014 - PR Newswire
Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement 1:30 a.m. Dec. 18, 2013 - PR Newswire
Positive Trend Scan List: Cell Therapeutics Inc, Micron Technology, Tiger Oil and Energy, General Motors, Twitter Inc 9:25 a.m. Dec. 10, 2013 - PR Newswire
Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting 1:30 a.m. Dec. 10, 2013 - PR Newswire
Integrated Safety and Efficacy Analysis of Phase 2 Clinical Trials of Pacritinib in Patients with Myelofibrosis and Low Platelet Counts Presented at ASH Annual Meeting 11:30 a.m. Dec. 9, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Cell Therapeutics and GKV-SV Reach Agreement on Pricing of PIXUVRI® (pixantrone) in Germany 1:30 a.m. Dec. 4, 2013 - PR Newswire
ACHN, CTIC, DRYS and FREE added to NASDAQ Active Stock Watch List at GSR 10:00 a.m. Dec. 2, 2013 - ACCESSWIRE
Bullish Stocks Analysis: Apple Inc, Facebook Inc, Cell Therapeutics Inc, Qihoo 360 Technology 9:32 a.m. Dec. 2, 2013 - ACCESSWIRE
Cell Therapeutics Receives $5 Million Milestone Payment for TRISENOX® 1:30 a.m. Dec. 2, 2013 - PR Newswire
Upcoming Investor Conference Presentations, Donations and Acquisitions - Research Report on Jazz Pharmaceuticals, DENTSPLY, Teleflex, DexCom, and Cell Therapeutics 8:00 a.m. Nov. 28, 2013 - PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Notable News Buzz & Trend Analysis: Bank of America, The Boeing Company, Cell Therapeutics Inc, General Electric, Exxon Mobil Corporation 9:39 a.m. Nov. 18, 2013 - PR Newswire
Insider Trading Reports for Facebook, Microsoft, Archer Daniels Midland, Zynga, Yahoo, and Apple 8:55 a.m. Nov. 18, 2013 - PR Newswire
Cell Therapeutics to Present at Upcoming Investor Conferences 1:30 a.m. Nov. 18, 2013 - PR Newswire
CTIC, TTS, EGHT and ICLD to NASDAQ Active Stock Watch List at EPR 10:11 a.m. Nov. 15, 2013 - ACCESSWIRE
Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership 7:36 a.m. Nov. 15, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

High Stakes at Bragg Companies' Crane Auction

Cranes, Cash, and Competition: Auction Insights Never thought a bunch of cranes and trucks could have me so interested, but here we are staring down one of the big ones this December. Bragg Companies plans to lift the lid on its fleet with an absolute auction conducted by none other than Jeff Martin Auctioneers. If you aren't in the loop, 'absolute' means no min bid,...

Kastle Partners with Bilt: Enhancing Workplace Rewards

Turning the Office into a Rewarding Experience It’s no secret the traditional office work setup is constantly evolving, often giving the workplace a brand-new set of challenges—and opportunities. Who would have thought that a partnership between Kastle and Bilt would set gears turning? The dynamic duo is about to redefine how people see going to the office. Kastle, a...

Bluerock's Split: What November's Trading Change Means

Bluerock's Strategic Move: Untying the Bundle Ah, Bluerock Acquisition Corp. II has thrown a new bone to the market. Starting November 16, 2026, the firm ain't keeping their Class A ordinary shares and warrants locked in a bundle anymore. This shift comes after they sold 17,250,000 units in their IPO back in September, which also saw underwriters fully clinking their...

Envista's $430M Senior Notes: A Market Move Decoded

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Fake Profiles Dominate Daters' Trust Issues Today

Trust Erosion in the Digital Dating Arena When it comes to modern dating, we're not talking hearts and flowers anymore; it's more like an elaborate game of detective work. A recent survey from Stud or Dud highlights the harsh reality that blind trust in digital dating profiles is about as outdated as sending a singing telegram. Almost half of the respondents pinned fake...

Plaza Tire Opens New Location on Route 66 Corridor

Expanding Horizons in the Midwest Another chapter in Plaza Tire Service's long history, folks, as it plants its flag deeper in Missouri with a new store right on the iconic Route 66. Yep, that means more options for drivers in central Missouri who've had enough of searching high and low for a reliable tire and auto service. What's New in St. Robert This latest joint isn't...

Li-Fire Tackles E-Bike Battery Fires Head-On

By Owen Jenkins Updated Nov 10, 2026 Category News Views 121

E-Bike Enthusiasm Meets Dangerous Fire Risks Imagine this: your sleek new e-bike, your pride and joy, becomes a ticking time bomb. That's the reality facing more folks than we'd like these days, as e-bike battery fires surge across the globe. Amidst the holiday hustle, Li-Fire hits the scene with a lifeline—a free replacement program for their E-bike Lithium Fire Cover....

Kia's Landmark Triple Win at 2026 Car Awards

Kia Makes History Well, folks, Kia has pulled off what many might have thought impossible. They snagged not one, not two, but three of Germany's Golden Steering Wheel awards. That's a real hat trick and a first for any non-European auto brand. With competition hotter than a stolen Tesla, Kia's not just keeping pace but setting it. The Golden Steering Wheel is one of those...

TIER IV and TUM Propel Driverless Buses in Munich

Revolutionizing Munich's Public Transit Let's dive headlong into one of the most ambitious autonomous driving projects that's underway in Europe's tech heart—Munich. Pioneering organizations, TIER IV and the Technical University of Munich (TUM), are combining forces to bring autonomous city buses to the bustling streets of Munich, powered by Autoware, the leading...

Yeastar 2026 Summit: AI, Growth, and Global Vision

Reflecting on Two Decades of Innovation Yeastar's 20th anniversary summit in Xiamen was no ordinary gathering. It wasn't just about handshakes and business cards. Nope, it was a celebration intertwined with a deeper vision of growth and influence in the UCaaS space that Yeastar has carved out for itself over the years. Here's a company that's been plotting its course for...